Galderma Announces Publication of Pivotal Phase 3 PERFECT 1 and PERFECT 2 Clinical Trials of Trifarotene in Patients with Moderate Facial and Truncal Acne in the Journal of the American Academy of Dermatology Press release
Galderma: New data reveals benefits of combining oral and topical treatment in patients with severe papulopustular rosacea Press release
Galderma Announces Positive Results from Phase 2b Study of Nemolizumab in Patients with Moderate-to-Severe Atopic Dermatitis Press release
Experts call for improved identification of ‘High Burden’ rosacea patients in everyday practice Press release
Jeannette R. Jakus, MD, MBA, Awarded American Academy of Dermatology Translational Biotechnology Fellowship Press release
